A new research paper from Matrix Global Advisors, Improvements in Medical Benefit Coverage of Biosimilars, finds that commercial medical benefit insurance coverage of biosimilars has been increasing since 2019 as the prices of these biosimilars have been declining in three disease areas.
Pharmaceutical Care
Management Association
505 9th Street NW, 10th Floor, Washington, DC 20004
© 2025 PCMA. All Rights Reserved.